简介: 【摘要】目的:分析肝硬化疾病中生化检验诊断的临床价值。方法:在本次研究中选择我院 2018年 2月 -2019年 12月收治的 60例肝硬化疾病患者作为研究组,选择同期接受体检的 60例健康者组作为对照组,对两组患者进行生化检验诊断,对诊断结果进行分析。结果:对对照组和研究组的各项指标进行分析,实践证明,研究组的 DBIL、 TBIL、 AST、 ALP、 ALT各项系数明显高于对照组,对对照组和研究组的 TP、 ALB、 CHE系数进行分析,研究组的各项系数明显少于对照组。结论:通过生化指标检查能对肝硬化患者的身体指标进行准确的诊断,了解患者的肝脏具体情况,进而为其提供科学有效的依据,因此生化指标检验值得推广和应用。 【关键词】肝硬化疾病;生化检验;临床价值 [Abstract] Objective: to analyze the clinical value of biochemical examination and diagnosis in liver cirrhosis. Methods: in this study, 60 patients with cirrhosis who were admitted to our hospital from February 2018 to December 2019 were selected as the study group, and 60 healthy people who received physical examination at the same time were selected as the control group to carry out biochemical test diagnosis on the two groups of patients and analyze the diagnosis results. Results: the data of DBIL, TBIL, AST, ALP and ALT in the study group were significantly higher than those in the control group. The data of TP, ALB and ChE in the study group and the control group were significantly lower than those in the study group. Conclusion: the biochemical index test can accurately diagnose the body index of patients with cirrhosis, understand the specific situation of the liver, and provide scientific and effective basis for them. Therefore, the biochemical index test is worthy of promotion and application.